ACCELERATED CLONE SELECTION AND CELL LINE DEVELOPMENT

Significance of the Topic

Direct measurement of critical process parameters and product quality attributes is essential for accelerating clone selection and cell line development. High quality data in near real time enhances understanding of bioprocess performance and supports timely decision making.

Objectives and Study Overview

This study aims to integrate the Sartorius Ambr 15 multiple parallel mini bioreactor system with the Waters BioAccord LC MS analyzer. The goal is to create a seamless workflow for two way data exchange that enables rapid intact mass analysis and links process inputs with product quality outputs.

Methodology and Instrumentation

The workflow is built around automated sample tracking and data sharing between systems

• Load sample lists from Ambr into BioAccord software
• Perform intact mass analysis to assess purity glycosylation and other product modifications
• Export processed results back to Ambr for integrated visualization and decision support

Instrumentation Used

The integrated platform comprises

• Sartorius Ambr 15 multiple parallel bioreactor system for small scale culture and sampling
• Waters BioAccord LC MS System providing high throughput intact mass analysis with user friendly workflows

Main Results and Discussion

The combined system enables correlation of over two hundred media components with critical quality attributes such as glycosylation profiles and purity metrics on a single platform. Continuous product quality feedback in near real time supports early identification of high performing clones and process conditions. The streamlined interface reduces manual data handling and accelerates iterative development cycles.

Benefits and Practical Applications

The integrated workflow offers

• Faster clone selection and cell line screening reducing development timelines
• Improved consistency in product quality and yield through real time monitoring
• Minimized downstream impurities by early detection of quality deviations
• Lower operational costs due to automation and reduced manual interventions

Future Trends and Potential Applications

Advances may include integration with artificial intelligence for predictive analytics expansion to additional critical quality attributes and implementation of closed loop control for adaptive bioprocess optimization. Further scaling of parallel bioreactor analytics and enhanced cloud connectivity will support decentralized development workflows.

Conclusion

The demonstrated integration of the Ambr 15 bioreactor system with the BioAccord LC MS platform provides a robust solution for accelerated clone selection and cell line development. High throughput intact mass analysis combined with seamless data exchange drives faster development timelines improved product consistency and cost savings.